Menu
0
Total price
0 €
PRICES include / exclude VAT
Homepage>BS EN ISO 20776-1:2020 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
sklademVydáno: 2024-05-08
BS EN ISO 20776-1:2020 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases

BS EN ISO 20776-1:2020

Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases

Format
Availability
Price and currency
Anglicky Secure PDF
Immediate download
247.28 €
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
24.73 €
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
74.18 €
Anglicky Hardcopy
In stock
247.28 €
Označení normy:BS EN ISO 20776-1:2020
Počet stran:30
Vydáno:2024-05-08
ISBN:978 0 580 52382 3
Status:Standard
DESCRIPTION

BS EN ISO 20776-1:2020


This standard BS EN ISO 20776-1:2020 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices is classified in these ICS categories:
  • 11.100.20 Biological evaluation of medical devices

This document describes one reference method, broth micro-dilution, for determination of MICs. The MIC can be a guide for the clinician, and reflects the activity of the drug under the described test conditions, by taking into account other factors, such as drug pharmacology, pharmacokinetics, or bacterial resistance mechanisms. This allows categorisation of bacteria as “susceptible” (S), “intermediate” (I), or “resistant” (R). In addition, MIC distributions can be used to define wild type or non-wild type bacterial populations. Although clinical interpretation of the MIC value is beyond the scope of this document, modifications of the basic method are required for certain antimicrobial agent - bacteria combinations to facilitate clinical interpretation. These modifications are included in a separate annex of this document. It is necessary to compare other susceptibility testing methods (e.g. disc diffusion or diagnostic test devices) with this reference method for validation, in order to ensure comparable and reliable results.